Index RUT P/E - EPS (ttm) - Insider Own 43.59% Shs Outstand 35.90M Perf Week -1.87%
Market Cap 684.19M Forward P/E - EPS next Y -1.47 Insider Trans -0.72% Shs Float 20.39M Perf Month 11.81%
Enterprise Value 523.25M PEG - EPS next Q -0.40 Inst Own 47.23% Short Float 5.22% Perf Quarter -1.61%
Income - P/S - EPS this Y 54.48% Inst Trans 5.40% Short Ratio 2.71 Perf Half Y -26.80%
Sales - P/B 3.76 EPS next Y 4.83% ROA - Short Interest 1.06M Perf YTD -26.85%
Book/sh 5.04 P/C 3.74 EPS next 5Y 33.13% ROE - 52W High 32.75 -42.20% Perf Year -
Cash/sh 5.05 P/FCF - EPS past 3/5Y -1.63% -ROIC - 52W Low 10.01 89.11% Perf 3Y -
Dividend Est. - EV/EBITDA - Sales past 3/5Y 58.89% -Gross Margin - Volatility 3.71% 3.85% Perf 5Y -
Dividend TTM - EV/Sales - EPS Y/Y TTM - Oper. Margin - ATR (14) 0.75 Perf 10Y -
Dividend Ex-Date - Quick Ratio 16.64 Sales Y/Y TTM - Profit Margin - RSI (14) 58.96 Recom 1.00
Dividend Gr. 3/5Y - - Current Ratio 17.19 EPS Q/Q - SMA20 3.64% Beta - Target Price 30.83
Payout - Debt/Eq 0.12 Sales Q/Q - SMA50 9.27% Rel Volume 0.25 Prev Close 18.63
Employees 281 LT Debt/Eq 0.11 Earnings May 08 AMC SMA200 -13.70% Avg Volume 392.61K Price 18.93
IPO Oct 11, 2024 Option/Short Yes / Yes EPS/Sales Surpr. 11.59% 6.39% Trades
Volume 99,519 Change 1.61%
Date
Action
Analyst
Rating Change
Price Target Change
Jun-24-25 Initiated BTIG Research
Buy
$30
Apr-04-25 Initiated Ladenburg Thalmann
Buy
$32
Nov-05-24 Initiated William Blair
Outperform
Nov-05-24 Initiated TD Cowen
Buy
$31
Nov-05-24 Initiated JP Morgan
Overweight
$32
Nov-05-24 Initiated Canaccord Genuity
Buy
$30
Nov-05-24 Initiated BofA Securities
Buy
$32
Jun-20-25 09:11AM
May-29-25 05:44AM
May-20-25 04:05PM
May-09-25 03:43AM
May-08-25 04:05PM
04:05PM
Loading…
Apr-30-25 04:05PM
08:00AM
Apr-24-25 04:05PM
Apr-23-25 02:58PM
Apr-21-25 05:00AM
Apr-16-25 10:40AM
Apr-15-25 08:00AM
Apr-07-25 01:04PM
Apr-05-25 11:00AM
Feb-26-25 02:15AM
04:05PM
Loading…
Feb-25-25 04:05PM
Feb-18-25 04:05PM
Feb-11-25 04:05PM
Dec-23-24 04:05PM
Nov-19-24 08:00AM
07:01AM
Nov-13-24 11:55PM
Nov-12-24 04:05PM
Nov-11-24 08:00AM
Nov-07-24 04:05PM
Nov-06-24 06:31AM
Oct-29-24 04:05PM
Oct-18-24 01:01AM
Oct-16-24 04:05PM
Oct-15-24 05:00PM
06:45AM
Loading…
Oct-14-24 06:45AM
Oct-11-24 05:00PM
10:15AM
08:45AM
Oct-10-24 11:27PM
Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
ROBERTSON REBECCA B Director Jun 18 '25 Sale 17.85 11,188 199,706 10,042 Jun 20 12:31 PM ROBERTSON REBECCA B Director Jun 17 '25 Sale 17.63 7,445 131,255 21,230 Jun 20 12:31 PM Copp Joshua Former Officer Jun 18 '25 Proposed Sale 17.85 11,188 199,715 Jun 18 01:23 PM ROBERTSON REBECCA B Director Jun 16 '25 Option Exercise 3.61 20,000 72,232 48,675 Jun 17 07:52 PM ROBERTSON REBECCA B Director Jun 16 '25 Sale 17.14 20,000 342,800 28,675 Jun 17 07:52 PM ROBERTSON REBECCA B Director Jun 17 '25 Proposed Sale 17.09 7,445 127,235 Jun 17 10:19 AM ROBERTSON REBECCA B Director Jun 16 '25 Proposed Sale 17.14 20,000 342,738 Jun 16 04:17 PM Copp Joshua Former Officer Jun 13 '25 Proposed Sale 18.00 6,859 123,484 Jun 13 04:22 PM Chao Xingjuan President and CEO Jun 03 '25 Option Exercise 2.24 25,000 56,000 801,022 Jun 05 06:34 PM Chao Xingjuan President and CEO Jun 03 '25 Sale 17.00 25,000 425,000 776,022 Jun 05 06:34 PM Chao Xingjuan Officer Jun 03 '25 Proposed Sale 17.15 25,000 428,750 Jun 03 10:06 AM Chao Xingjuan President and CEO May 15 '25 Option Exercise 1.02 73,871 75,060 776,022 May 19 12:33 PM Chao Xingjuan President and CEO May 15 '25 Sale 16.96 25,000 424,000 727,151 May 19 12:33 PM Chao Xingjuan Officer May 15 '25 Proposed Sale 16.59 25,000 414,750 May 15 10:47 AM Chao Xingjuan President and CEO Apr 23 '25 Sale 15.11 15,628 236,139 727,151 Apr 24 04:47 PM Chao Xingjuan President and CEO Apr 22 '25 Sale 15.06 300 4,518 742,779 Apr 24 04:47 PM Chao Xingjuan Officer Apr 23 '25 Proposed Sale 15.11 15,628 236,085 Apr 23 04:11 PM Chao Xingjuan Officer Apr 22 '25 Proposed Sale 15.06 300 4,518 Apr 22 04:10 PM Chao Xingjuan President and CEO Apr 17 '25 Sale 15.02 5,700 85,614 746,451 Apr 21 09:31 PM Chao Xingjuan President and CEO Apr 21 '25 Sale 15.03 3,372 50,681 743,079 Apr 21 09:31 PM Chao Xingjuan Officer Apr 21 '25 Proposed Sale 15.03 3,372 50,664 Apr 21 04:07 PM Chao Xingjuan Officer Apr 17 '25 Proposed Sale 15.02 5,700 85,612 Apr 17 04:13 PM Blumberg Scott Chief Financial Officer Dec 23 '24 Option Exercise 2.26 1,000 2,260 89,366 Dec 26 11:23 AM TPG GP A, LLC 10% Owner Oct 15 '24 Buy 17.00 380,268 6,464,556 3,967,422 Oct 17 04:14 PM Tammenoms Bakker Juliet Director Oct 15 '24 Buy 17.00 237,234 4,032,978 2,475,110 Oct 16 04:18 PM
